Musculoskeletal Transplant Foundation

Form 483 issued March 13, 2009 · Edison, New Jersey

Inspection
Jan 27 – Mar 13, 2009
Observations
7
Pages
5
FEI number
3001236616

In short: On March 13, 2009, FDA issued a Form 483 with 7 observations to Musculoskeletal Transplant Foundation in Edison, New Jersey (FEI 3001236616) after an inspection that ran Jan 27 – Mar 13, 2009. The investigators were Dawn L. Wydner, Juanita P. Versace, Sarah M. Forney and Susan T. Hadman. Most observations concern hCT/P and production & process controls.

At a glance

5 of 7 observations on this 483 concern hct/p.

HCT/P5
Production & process controls1
CAPA1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Written representation that processing methods reduce the risk of transmission of communicable disease by HCT/Ps was…

  2. 02

    Environmental conditions are not monitored when such conditions could cause contamination or cross contamination…

  3. 03

    Specified requirements for in-process…

  4. 04

    You did not ensure that establishment(s) that by contract, agreement or arrangement, perform manufacturing steps for…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Musculoskeletal Transplant Foundation?

FDA listed 7 observations on this Form 483, mostly about hCT/P, production & process controls and cAPA. The opening words of each observation are shown on this page.

Who inspected Musculoskeletal Transplant Foundation?

Dawn L. Wydner, Juanita P. Versace, Sarah M. Forney and Susan T. Hadman are named on this Form 483, for the inspection of Jan 27 – Mar 13, 2009. Each investigator has a profile showing what they cite most.

When was Musculoskeletal Transplant Foundation inspected by FDA?

The inspection ran Jan 27 – Mar 13, 2009, and the Form 483 is dated March 13, 2009.

How do I get the full Form 483 for Musculoskeletal Transplant Foundation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free